Targeting BCMA in Mutliple Myeloma
Multiple Myeloma
Multiple myeloma is the second most commonly diagnosed blood cancer, after non-Hodgkin lymphoma. Multiple myeloma is a cancer in which immortalized plasma cells accumulate in the bone marrow, causing severe pain, anemia, and kidney failure. Multiple myeloma was once considered universally fatal.
Improved diagnostic methods and innovative treatments are improving patient outcomes. Still, nearly all patients eventually relapse a...
